Filing Details
- Accession Number:
- 0001549595-24-000153
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-01 17:57:13
- Reporting Period:
- 2024-11-01
- Accepted Time:
- 2024-11-01 17:57:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1549595 | Nurix Therapeutics Inc. | NRIX | Pharmaceutical Preparations (2834) | 270838048 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1817217 | Hans Houte Van | C/O Nurix Therapeutics, Inc. 1700 Owens Street, Suite 205 San Francisco CA 94158 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-11-01 | 3,546 | $24.28 | 33,724 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- Represents the weighted average sale price. The lowest price at which shares were sold was $24.04 and the highest price at which shares were sold was $24.70. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
Billionaire Hedge Funds
